Thermo Fisher Scientific Expands HeavyPeptide Collection, Offering Customers Greater Value and Choice

Source : Thermo Fisher Scientific Inc.

ULM, Germany (August 24, 2009) – Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it is expanding its industry-leading offering of HeavyPeptide kits for quantification of proteins through mass spectrometry. Providing customers with greater value and choice, the expanded Thermo Scientific HeavyPeptide Aqua™ line will debut at the 8th Annual World Congress of the Human Proteome Organisation (HUPO) in Toronto, Sept. 26-30. The collection includes:

  • HeavyPeptide AQUA Ultimate™ — the industry standard for absolute quantification, delivered in solution with known concentration and a precision level of +- 5 percent.

  • HeavyPeptide AQUA QuantPro™ — a more affordable alternative when ultimate precision is not necessary.

  • HeavyPeptide AQUA Basic — competitively priced and designed for customers engaged in relative quantification who prefer to work with lyophilized (powdered) products.

“With this expanded range of products, we are giving customers the choice of precision, grade and price,” said Joel Louette, commercial director for Thermo Scientific Custom Biopolymers.

In addition, the company continues to offer the Thermo Scientific HeavyPeptide™ FasTrack service to accelerate initial peptide selection and purification. The service provides customers with a choice of crude heavy peptides to develop their mass spectrometry assays and identify the best proteotypic peptide candidates. Once a customer has identified these candidates, retained crude stock is used to quickly produce the final purified heavy peptides to be used in the experiments. Crude heavy peptides are also now available independent of the FasTrack service.

The new HeavyPeptide AQUA offering will be exhibited during the HUPO Congress at Toronto’s Westin Harbour Castle. Members of the Thermo Scientific Custom Biopolymers team will be available to answer customer questions. While supplies last, vouchers for free HeavyPeptide AQUA sample kits will also be available.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, enabling our customers to make the world healthier, cleaner and safer. With 2008 revenues of $10.5 billion, we have approximately 34,000 employees and serve over 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental and industrial process control settings. Serving customers through two premier brands, Thermo Scientific and Fisher Scientific, we help solve analytical challenges from routine testing to complex research and discovery. The Thermo Scientific brand represents a complete range of high-end analytical instruments as well as laboratory equipment, software, services, consumables and reagents to enable integrated laboratory workflow solutions. Fisher Scientific provides a complete portfolio of laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety and education. Together, we offer the most convenient purchasing options to customers and continuously advance our technologies to accelerate the pace of scientific discovery, enhance value for customers and fuel growth for shareholders and employees alike. Visit


  • <<
  • >>

Articles List

  • Point-of-Care Diagnostic Tests Streamline Patient Care

    Point-of-Care Diagnostic Tests Streamline Patient Care

    Point-of-care (POC) tests have evolved from a unique approach for gathering information to an almost routine, more efficient solution for patients to receive care without having to travel to different locations for lab work. Often POC tests can provide faster time to results, which translates into better patient care. Today many POC tests are available; they focus on everything from blood chemistry to HIV infection. Here is a glimpse into common areas of POC testing and the processes involved in developing new POC diagnostic tests.
  • Cell Signaling: Sussing out the Kinases

    Cell Signaling: Sussing out the Kinases

    Broadly speaking, querying cell signaling often means looking at phosphorylation or its proxy—by looking for the presence of an “activated” kinase or the result of its activity (the phosphorylated substrate) or even for a by-product of that activity (like ADP). Here is a sampling of some ways researchers are examining cell signaling by monitoring kinase activity.

Disqus Comments